title: Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality.
authors.affiliation: Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA. lradvanyi@mdanderson.org
authors.forename: Laszlo
authors.initials: L
authors.lastname: Radvanyi
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000235:genetics* / Q000276:immunology*
chemical_list: D000951:Antigens, Neoplasm
references.citation: Nat Med. 2007 Jan;13(1):54-61
references.pmid: 17187072
references.citation: Expert Opin Biol Ther. 2010 Jun;10(6):983-91
references.pmid: 20420527
references.citation: Cancer Res. 2009 Oct 15;69(20):8058-66
references.pmid: 19826050
references.citation: Mol Ther. 2004 May;9(5):757-64
references.pmid: 15120337
references.citation: PLoS Negl Trop Dis. 2012;6(3):e1567
references.pmid: 22448291
references.citation: Nat Biotechnol. 2012 Mar 18;30(4):337-43
references.pmid: 22426030
references.citation: Immunol Rev. 2004 Jun;199:251-63
references.pmid: 15233739
references.citation: Nat Rev Drug Discov. 2012 Feb 03;11(3):215-33
references.pmid: 22301798
references.citation: Mol Ther. 2013 Aug;21(8):1507-16
references.pmid: 23752316
references.citation: Nat Med. 2011 Jun 19;17(7):854-9
references.pmid: 21685898
references.citation: Vaccine. 2012 Mar 28;30(15):2523-34
references.pmid: 22314133
references.citation: Cancer Cell. 2013 Jun 10;23(6):811-25
references.pmid: 23764003
references.citation: Nature. 2012 Feb 08;482(7385):400-4
references.pmid: 22318521
references.citation: J Clin Invest. 2009 Jun;119(6):1417-9
references.pmid: 19487817
references.citation: Eur J Cancer. 2013 Apr;49(6):1297-304
references.pmid: 23290787
references.citation: J Immunol. 2011 Oct 15;187(8):4109-18
references.pmid: 21908736